<p>Biologic agents targeting key proteins involved in bone homeostasis are revolutionizing the management of osteoporosis. New clinical data support the use…
nature.com
Romosozumab rapidly and dramatically reduces vertebral fractures compared with placebo in FRAME, and bone-enhancing effects continue after patients…
medscape.com
MADRID – Investigational bone-building drug looks promising, but safety concerns emerge.
mdedge.com
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis (The ARCH Trial)
nejm.org
ARCH (Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk)
Romosozumab Followed by Alendronate Bests Alendronate Alone for Fracture Prevention
By Jill Stein…
dgnews.docguide.com
Romosozumab — Promising or Practice Changing?
Editorial from The New England Journal of Medicine — Romosozumab — Promising or Practice Changing?
nejm.org
rheumnow.com
Phase 3 BRIDGE study results show…
pharmabiz.com
A complete response letter is not an unexpected heartbreak for Evenity after Phase 3 data showed some worrying safety signals.
biopharmadive.com